INTRODUCTION
Adolescence and young adulthood is a challenging period of physical, emotional, cognitive, and social development. 1 Important and complex age-related developmental tasks need to be achieved, such as developing one's own identity, becoming independent from parents, completing education, pursuing gainful employment, dating, and having children. 2, 3 A cancer diagnosis and its treatment compounds these normative developmental challenges of adolescence and young adulthood and can negatively affect the physical, psychological, spiritual/existential, and social functioning of adolescents and young adults (AYAs). 4, 5 Cross-sectional studies have demonstrated that AYAs with cancer report greater challenges in social functioning compared with the general AYA population 4, 5 and older patients with cancer. 6 Social functioning has been defined as "those activities considered essential for performance of the several roles which each individual by virtue of his membership in social groups is called upon to carry out." 7 An individual's social role can be defined in terms of fulfilling a recognized position in society (eg, as a parent, student, or employee). 8 Cancer and its treatment often alter social roles and limit the social activities of patients. 9 For AYAs in particular, a cancer diagnosis can disrupt social maturation, the process by which a young person develops self-views, social cognition, awareness, and emotional regulation that guides him or her throughout the remainder of his or her life. [10] [11] [12] AYAs with cancer frequently report difficulties in maintaining or making new social relationships because of the long-term effects of treatment (hindering reintegration into school/work) or feeling anxious concerning 'fitting into" their peer group again. [13] [14] [15] Poor social functioning may negatively affect physical and mental health outcomes.
Understanding social functioning among AYA patients with cancer over time is important to learn who remains at risk of a poor outcome and to determine potentially relevant services and resources required to serve them. Therefore, the purpose of the current study was: 1) to examine social functioning among AYAs within the first 2 years after a cancer diagnosis and compare their scores with those of population norms; 2) identify the trajectories of social functioning over time; and 3) determine sociodemographic, clinical, and psychosocial correlates of these social functioning trajectories.
MATERIALS AND METHODS
A prospective, longitudinal, multicenter study conducted among AYA patients with cancer assessed health-related quality of life (HRQOL) over the 2 years after the initial diagnosis of cancer. The data were collected within the first 4 months of diagnosis and then again 12 
Patients
Research staff at each participating institution monitored clinic registration rosters and subsequently approached 286 eligible patients between March 2008 and April 2010. Of these, 58 patients did not participate, either because physicians denied access to patients who they believed were too sick to participate or patients refused to participate. Of the 228 AYA patients who consented to the study, 12 did not return a survey after providing consent and 1 died. Thus, the overall participation rate was 75% (215 patients). Eligibility criteria included patients aged 15 to 39 years (and those patients aged 14 years who were expected to turn 15 years old during treatment) who were diagnosed with any form of invasive cancer (any stage of disease) for the first time and who were able to read and understand English or Spanish. A 4-month eligibility window for baseline recruitment was determined based on referral patterns in which many AYA patients are first diagnosed in a communitybased setting and then transferred to tertiary care centers for further staging and treatment. The age range proposed for the current study was the same as that in the National Cancer Institute's Adolescent and Young Adult Oncology Progress Review Group. 17 
Measures
Social functioning was measured by a subscale of the Medical Outcomes Study Short Form 36 Health Survey (version 2; SF-36). The SF-36 is a widely used and wellvalidated instrument that assesses 8 aspects of physical and mental health functioning: Physical Functioning, role function-physical, bodily pain, social functioning, mental health, role function-emotional, vitality, and general health. 18 Two of the 36 items measure the degree to which physical or emotional problems interfere with usual social life/normal social activities with family, friends, or neighbors. Together, these 2 items form the social functioning scale. Scale scores were calculated according to the manual of the SF-36. 18 Scores could range from 0 to 100, with higher scores representing better functioning.
Sociodemographic data, including time-invariant information (age at diagnosis, sex, and race) and timevariant information (employment/school status and relationship/marital status) were reported by patients. Age at diagnosis was categorized into 3 groups (aged 14-17 years, aged 18-25 years, and aged 26-39 years) to approximate developmental life stages.
2 Employment/school status and relationship/marital status were assessed at each time point. Given the geographic locations of several sites and their respective catchment areas consisting of high concentrations of Latinos, race was categorized into 3 categories: white, Hispanic/Latino, and other.
Additional clinical data were obtained from medical charts and included the type of cancer, types of treatment (chemotherapy, radiotherapy, and surgery), and treatment status (on vs off treatment). Surveillance, Epidemiology, and End Results (SEER) codes and epidemiological data were used to organize cancer types into 3 categories of severity of disease based on prognosis for survival: diseases with expected 5-year survival rates of >80%, diseases with expected 5-year survival rates of 50% to 80%, and diseases with expected 5-year survival rates of <50%. 17, 19, 20 In addition, via self-report, a symptom checklist, derived by the investigators, elicited subject endorsement of 11 common treatment-related side effects during the past month (ie, shortness of breath; problems with memory, attention, or concentration; frequent or severe stomach pain, pain in your chest [heartburn] , or indigestion; ringing in the ears; pain in your joints; weight loss; frequent fevers; lack of sleep or trouble sleeping; frequent tiredness or fatigue; frequent mouth sores that impact eating and drinking; and frequent headaches), which were summed and considered in statistical analyses. 21 Social support was measured with the MOS Social Support survey, which is a 19-item questionnaire assessing the degree to which a chronically ill patient perceives the availability of functional social support. 22 Domains assessed include tangible support (eg, "someone to help you if you were confined to bed"), affectionate support (eg, "someone who hugs you"), emotional-informational support (eg, "someone you can count on to listen to you when you need to talk"), and positive social interaction (eg, "someone to get together with for relaxation").
Response values occur on a 5-point Likert scale that ranges from 1 ("none of the time") to 5 ("all of the time"). The overall index was calculated by averaging scores across all items, with higher scores indicating greater levels of social support. Prior use of this scale with patients with chronic illnesses has provided evidence of high internal consistency (Cronbach a 5 .97).
Psychological distress was measured by the Brief Symptom Inventory 18 (BSI-18), which contains 18 selfreport items assessing the extent to which a respondent has been bothered by psychological distress symptoms over the past 7 days. 23 A Global Symptom Index was calculated, with higher scores indicating greater psychological distress. The Brief Symptom Inventory 18 has demonstrated reliability and validity in >400 research studies, including samples of healthy adolescents aged 13 years. 23 The Cronbach a coefficient of the Global Symptom Index was .91.
Unmet care needs were assessed by a 15-item instrument specifically developed to measure AYAs' expressed needs for 1) information or informational resources, 2) counseling services, and 3) practical support services. 21, 24 Respondents indicate which of 15 services they have used and which they would like to use in the future. Response categories include the following: "Have used and would like to use more," "Have used and have no further need," "Have NOT used but would like to," and "Have NOT used and have no need." Unsatisfied need is operationalized as a desire to use a service, regardless of whether the service had been used in the past. The total number of unsatisfied needs was calculated.
Statistical Analysis
Differences in sociodemographic and clinical characteristics between patients who completed the 24-month follow-up questionnaire and those who did not respond or had died were compared with the chi-square test or analysis of variance, when appropriate. Patients who did not complete the 24-month follow-up questionnaires were excluded from further analyses.
We first analyzed mean differences over time in social functioning using Student t tests for paired data. In addition, scores were compared with US population norms (weighted means and pooled standard deviations for individuals aged 18-44 years 18 ) at each time point by independent Student t tests. Furthermore, to depict changes over time, a participant was assigned to a baseline and follow-up category based on the distance from the US population norms. Clinically relevant differences were determined according to the Norman rule of thumb of 0.5 standard deviations (SD). 25 High represents at least 0.5 SD greater than the age-based norm (>95.5), normal represents within 0.5 SD of the age-based norm (74.5-95.5), and low represents at least 0.5 SD less than the agebased norm (<74.5). Thereafter, the following groups were formed: those with low scores at all time points (consistently low social functioning), those with scores improving from low to normal/high (improved social functioning), those with scores decreasing from high/normal to low (worsening social functioning), and those with high or normal scores at all time points (consistently high/ normal social functioning).
To examine differences in sociodemographic, clinical, and psychosocial characteristics between the 4 groups, the chi-square test or analysis of variance was used when appropriate. Multiple logistic regression analysis was performed to investigate the independent association between sociodemographic, clinical, and psychosocial factors and the group with consistently low social functioning (vs the other 3 groups). Covariates were included if they were near a statistically significant (P<.10) association with social functioning at the univariate level and included race, employment status, treatment status, number of symptoms, psychological distress, and negative and positive impact of cancer.
RESULTS
A total of 215 patients completed the baseline survey, 165 patients completed the 12-month follow-up survey, and 141 patients completed the 24-month follow-up survey. Mortality accounted for 27% of total attrition at the 24-month follow-up (38 patients). After excluding those patients who had died, only 36 patients (25%) did not respond to the 24-month follow-up survey. Respondents to the 24-month follow-up questionnaire were younger, Original Article had a lower educational level, and more often received chemotherapy compared with nonrespondents and also dead patients at follow-up. Baseline demographics and clinical characteristics are shown in Table 1 .
Change in HRQOL Over Time Figure 1 summarizes the observed means for the social functioning subscale of the SF-36 at each of the 3 measurement points and their changes over time. In the aggregate, participants reported significant increases in social functioning from baseline to the 24-month follow-up survey. These increases over 24 months are fully accounted for by the observed increase from baseline to the 12-month follow-up survey. Between the 12-month and 24-month follow-up surveys, a small but nonsignificant decrease in social functioning was found. Compared with population norms, AYA patients reported significantly lower social functioning at all 3 measurement points ( Fig. 1) . At the 24-month follow-up, scores were still clinically lower than population norms. Figure 2 illustrates the change in social functioning from a more patient-centered perspective. Among participants, 66 (47%) demonstrated improved social functioning, 12 (9%) demonstrated consistently high/normal social functioning, 18 (13%) demonstrated worsening social functioning, and 45 participants (32%) demonstrated consistently low social functioning.
Sociodemographic, Clinical, and Psychosocial Correlates of Stability in Social Functioning
AYA patients with cancer who had consistently low social functioning were more often off treatment at the time of follow-up, reported more physical symptoms at baseline and follow-up, perceived less social support at baseline, and had higher levels of psychological distress at both baseline and follow-up compared with the other 3 groups (Table 2 ). No differences between the groups were found with regard to sociodemographic factors and cancerrelated factors.
Multivariable logistic regression analysis was conducted to determine factors associated with chronicity of low social functioning (consistently low social functioning group) versus nonchronicity (combined improved social functioning, consistently high/normal social functioning, and worsening social functioning groups). Results suggested that the 45 AYA patients in the chronic group were more often off treatment and reported higher levels of psychological distress at follow-up (Table 3) .
DISCUSSION
In this prospective follow-up study, social functioning for recently diagnosed AYA patients with cancer was worse when compared with age-matched population norms. Although it improved somewhat over the 2 years after diagnosis, social functioning remained significantly lower compared with population norms after 24 months. The results of the current study are consistent with previously conducted cross-sectional studies demonstrating that social functioning was among the most severely affected HRQOL domains among AYA patients with cancer. [4] [5] [6] The results from the current study add to the current body of knowledge by indicating that improvements in social functioning take place within the first year after Abbreviations: BMT, bone marrow transplantation; SD, standard deviation. a Question was worded as follows: "Are you currently married, living together, or in a significant committed relationship?" b Response categories included the following: on temporary medical leave/disability, unemployed, and permanently unable to work. c Response categories included the following: employed full time, employed part time, full-time homemaker, and full-time student. d Question was worded as follows: Have you experienced any of the following problems in the past month, whether related to cancer or not? Categories were as follows: shortness of breath; problems with memory, attention, or concentration; frequent or severe stomach pain, pain in your chest (heartburn) or indigestion; ringing in the ears; pain in your joints; weight loss; frequent fevers; lack of sleep or trouble sleeping; frequent tiredness or fatigue; frequent mouth sores that impact your eating and drinking; frequent headaches.
diagnosis and that between 12 and 24 months, no significant additional improvement occurs (on average). Nearly 32% of the AYA cancer survivors reported consistently low social functioning over time. Compared with AYA cancer survivors with improved social functioning, consistently high/normal social functioning, and worsening social functioning over time, these individuals were more often off treatment. This could stem from the possibility that the transition from being a patient with cancer to being an off-treatment survivor often is fraught with new challenges as AYA cancer survivors are confronted with survivorship concerns about their future lives, including negative impacts on an individual's financial situation, body image, work plans, relationship with spouse/significant other, and plans for having children. 26 Although not significant, AYA cancer survivors who consistently scored low on social functioning were less often involved in school or work at baseline and at the 24-month follow-up survey, whereas remaining employed or in school during treatment may help AYA patients to maintain normalcy and social reintegration with friends, peers, and others, thus minimizing life disruption. 11 In addition to "curing" the underlying disease, the imperative long-term goal of any treatment strategy for cancer should include the reintegration of a survivor into social and work roles. 27 Interventions that promote social integration for AYA cancer survivors (eg, supportive and vocational counseling) directly after treatment appear necessary.
AYA cancer survivors who consistently score low on social functioning reported more physical symptoms and had higher levels of psychological distress, possibly reflecting an impaired ability to fulfill customary social activities due to the effects of cancer. Alternatively, this persistent level of low social functioning may stem in part from individual differences in generalized loneliness or negative affectivity (eg, a temperamental predisposition toward negative emotions) that preceded the onset of cancer (and was possibly exacerbated by cancer). This finding indicates that posttreatment symptom management to diminish debilitating physical symptoms and psychosocial interventions to reduce psychological distress around the time AYA individuals go from receiving to being off treatment would be helpful for this group of patients to help them reintegrate fully into society. In addition, AYA cancer survivors who consistently score low on social functioning perceived themselves to receive less social support around the time of diagnosis. Previous research has reported that young adult cancer survivors experience feelings of isolation because they perceive themselves as being "different" from their peers. 28 These studies also found that AYA individuals have a more intense feeling of isolation when they do not know any other AYA cancer survivors. This indicates that age-specific social support strategies are needed for AYA cancer patients, for whom friendships and social roles are key components of identity development and mental health. The health care environment can support the maintenance of a sense of normalcy by having accessible visiting hours and a welcoming environment that encourages visiting the hospitalized AYA patient. 29 In addition, inpatient wards and social space facilities within the hospital will provide AYA patients with cancer the opportunity to connect, share experiences, learn from each other, and feel they are genuinely understood. 30 Furthermore, online social network/peer support groups and games as forms of electronic communication for AYA patients have been shown to significantly reduce feelings of social isolation and improve knowledge, self-efficacy, problem-solving skills, and effective interpersonal interactions. [30] [31] [32] The current study was limited by a lack of detailed objective information regarding patients' health status, disease stage, and treatment specifics (eg, dosages and duration of radiotherapy or chemotherapy). Therefore, the influence of these factors on social functioning could not be determined. However, to the best of our knowledge, except for physical symptoms, no other sociodemographic and clinical factors were found to be associated with the stability of social functioning. This is in accordance with prior research suggesting that subjective perceptions of one's experiences are better predictors of HRQOL outcomes compared with objective clinical conditions or sociodemographic indicators. [33] [34] [35] Further investigations are needed that account for the effects of clinical conditions (eg, long-term late effects of therapies), social/environmental influences (eg, changing social and labor conditions affecting the financial and work lives of AYA individuals, changing timetables and priorities for developmental tasks, sexual and gender plurality, and expanding cultural diversity), and personal characteristics (coping strategies and personality) on social functioning and QOL outcomes. 36 Furthermore, the findings of the current study are somewhat limited in that approximately 25% of the eligible sample pool was inaccessible because these patients were too ill to participate. Their absence from the study limits the generalizability of its results. Finally, with regard to instrumentation, the current study relied on a generic instrument with limited evidence of validity and reliability in study samples consisting of individuals aged <18 years. In addition, although to the best of our knowledge it is one of the most widely used measures for social functioning in cancer survivor studies, the SF-36 social functioning scale only captures the mental health and perception of interactions components of social health, and not social participation and behavior as such. 9 An instrument assessing the performance of and satisfaction with social roles within 3 contexts (family/ friends, work/school, and leisure activities) is needed in future research. 37 The results of the current study demonstrate that although improved over time, the social functioning of AYA cancer survivors remained compromised 24 months after their primary diagnosis. Nearly one-third of the patients continued to be at risk of poor social functioning. Reducing physical symptoms and psychological distress and enhancing social support by intervention during the period after treatment may potentially help these young survivors to better reintegrate into society.
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